Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - OTHER CURRENT LIABILITIES
Other Current Liabilities REGN - Regeneron Pharmaceuticals, Inc.
2.36 B
LAST VALUE
3.36%
2 YEAR CAGR
25.70%
5 YEAR CAGR
28.78%
10 YEAR CAGR